Article History
Received: 9 June 2023
Accepted: 21 August 2023
First Online: 12 September 2023
Declarations
:
: Yousif Subhi has received speakers fees from Bayer and Roche, not related to this work. Ivan Potapenko, Lasse Malmqvist, and Steffen Hamann have nothing to disclose.
: This study was designed as a study of publicly accessible software (ChatGPT) and we neither obtained nor analyzed clinical records or samples from patients or other study subjects. According to Danish law, such studies do not require institutional review board approval. All aspects of this study adhered to the tenets of the Declaration of Helsinki.